Siblings Books/Book Section [1/1] Conference Papers/Meeting Abstract [9/12] Periodical Articles [43/44] Collection Statistics Item counts issued in 3 years:1(12.50%) Items With Fulltext:0(0.00%) Last Update: 2025-03-12 17:50 Top Upload Loading... Top Download Loading... Recent Submissions AhR-ROR-γt complex as a biomarker a... 作為用於自體免疫疾病及IL-17 相關疾病之生物標記及治療標靶之AhR... MAP4K3作为自体免疫疾病、癌症、发炎及IL‑17相关疾病的生物标记... GLK介在疾患の治療薬同定方法 자가면역 질병, 암, 염증 및 ＩＬ-１７-관련 질병에 대한 바이... MAP4k3 as a biomarker and therapeti... 絲裂原蛋白激酶激酶激酶激酶３(MAP4K3)作為自體免疫疾病、癌症、發... Map kinase kinase kinase kinase 3 (...

Jump to a point in the index: (Choose year) 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 1-8 of 8. (1 Page(s) Totally) 1  View [10|25|50] records per page

Date	Title	Relation
2023-06-11	作為用於自體免疫疾病及IL-17 相關疾病之生物標記及治療標靶之AhR-ROR-γt 複合體	TWI804669/2023-06-11
2022-06-14	AhR-ROR-γt complex as a biomarker and therapeutic target for autoimmune disease and IL-17A-associated disease	US11360080/2022-06-14
2018-06-15	GLK介在疾患の治療薬同定方法	JP6351503/2018-06-15
2017-09-22	MAP4K3作为自体免疫疾病、癌症、发炎及IL‑17相关疾病的生物标记及治疗标的	CN103827310/2017-09-22
2017-07-19	MAP4k3 as a biomarker and therapetic target for autoimmune disease, cancer, inflammation and il-17- associated disease	EP2732045/2017-07-19
2016-07-11	자가면역 질병, 암, 염증 및 ＩＬ-１７-관련 질병에 대한 바이오마커 및 치료 표적으로서 ＭＡＰ４Ｋ３	KR10-1640326/2016-07-11
2015-12-01	絲裂原蛋白激酶激酶激酶激酶３(MAP4K3)作為自體免疫疾病、癌症、發炎及IL-17相關疾病的生物標記及治療標的	TWI510629/2015-12-01
2014-09-30	Map kinase kinase kinase kinase 3 (MAP4K3) as a biomarker and therapeutic target for autoimmune disease, cancer, inflammation and IL-17-associated disease	US8846311/2014-09-30

Showing items 1-8 of 8. (1 Page(s) Totally) 1  View [10|25|50] records per page